Mitiperstat (AZD4831) is the potent inhibitor of myeloperoxidase (MPO). Mitiperstat is particularly useful in the research of proplaxis of cardiovascular disorders such as heart failure and coronary artery disease related conditions (extracted from patent US20160152623A1)[1].
[1]. Tord Bertil INGHARDT, et al. 1-[2-(AMINOMETL)BENZYL]-2-THIOXO-1,2,3,5-TETRADRO-4H-PYRROLO[3,2-d]PYRIMIDIN-4-ONES AS INHIBITORS OF MYELOPEROXIDASE. Patent US20160152623A1.
















